National Health Investors Future Growth
Future criteria checks 2/6
National Health Investors is forecast to grow earnings and revenue by 3.7% and 14.3% per annum respectively. EPS is expected to decline by 1.2% per annum. Return on equity is forecast to be 9.6% in 3 years.
Key information
3.7%
Earnings growth rate
-1.2%
EPS growth rate
Health Care REITs earnings growth | 0% |
Revenue growth rate | 14.3% |
Future return on equity | 9.6% |
Analyst coverage | Low |
Last updated | 18 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 423 | 136 | N/A | N/A | 2 |
12/31/2025 | 352 | 134 | N/A | N/A | 4 |
12/31/2024 | 320 | 123 | N/A | N/A | 4 |
12/31/2023 | 320 | 136 | 181 | 184 | N/A |
9/30/2023 | 311 | 105 | 176 | 178 | N/A |
6/30/2023 | 307 | 110 | 171 | 171 | N/A |
3/31/2023 | 290 | 92 | 178 | 178 | N/A |
12/31/2022 | 279 | 66 | 185 | 185 | N/A |
9/30/2022 | 278 | 71 | 192 | 192 | N/A |
6/30/2022 | 275 | 68 | 198 | 198 | N/A |
3/31/2022 | 289 | 85 | 193 | 193 | N/A |
12/31/2021 | 297 | 112 | 211 | 211 | N/A |
9/30/2021 | 307 | 142 | 213 | 213 | N/A |
6/30/2021 | 317 | 154 | 224 | 224 | N/A |
3/31/2021 | 327 | 159 | 232 | 232 | N/A |
12/31/2020 | 330 | 185 | 232 | 232 | N/A |
9/30/2020 | 332 | 190 | 233 | 233 | N/A |
6/30/2020 | 330 | 190 | 231 | 231 | N/A |
3/31/2020 | 325 | 186 | 224 | 224 | N/A |
12/31/2019 | 318 | 160 | 241 | 241 | N/A |
9/30/2019 | 310 | 155 | 236 | 236 | N/A |
6/30/2019 | 303 | 154 | 233 | 233 | N/A |
3/31/2019 | 298 | 152 | 233 | 233 | N/A |
12/31/2018 | 295 | 154 | 208 | 208 | N/A |
9/30/2018 | 292 | 155 | 208 | 208 | N/A |
6/30/2018 | 288 | 153 | 205 | 205 | N/A |
3/31/2018 | 285 | 154 | 198 | 198 | N/A |
12/31/2017 | 279 | 159 | 198 | 198 | N/A |
9/30/2017 | 273 | 163 | N/A | 194 | N/A |
6/30/2017 | 264 | 157 | N/A | 189 | N/A |
3/31/2017 | 255 | 163 | N/A | 185 | N/A |
12/31/2016 | 247 | 152 | N/A | 177 | N/A |
9/30/2016 | 240 | 165 | N/A | 173 | N/A |
6/30/2016 | 235 | 165 | N/A | 168 | N/A |
3/31/2016 | 230 | 152 | N/A | 167 | N/A |
12/31/2015 | 227 | 149 | N/A | 164 | N/A |
9/30/2015 | 215 | 122 | N/A | 154 | N/A |
6/30/2015 | 201 | 114 | N/A | 145 | N/A |
3/31/2015 | 190 | 108 | N/A | 136 | N/A |
12/31/2014 | 177 | 102 | N/A | 126 | N/A |
9/30/2014 | 165 | 98 | N/A | 123 | N/A |
6/30/2014 | 151 | 95 | N/A | 118 | N/A |
3/31/2014 | 134 | 88 | N/A | 109 | N/A |
12/31/2013 | 118 | 78 | N/A | 104 | N/A |
9/30/2013 | 108 | 81 | N/A | 97 | N/A |
6/30/2013 | 102 | 72 | N/A | 92 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WX6's forecast earnings growth (3.7% per year) is above the savings rate (0.7%).
Earnings vs Market: WX6's earnings (3.7% per year) are forecast to grow slower than the German market (15.8% per year).
High Growth Earnings: WX6's earnings are forecast to grow, but not significantly.
Revenue vs Market: WX6's revenue (14.3% per year) is forecast to grow faster than the German market (5% per year).
High Growth Revenue: WX6's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: WX6's Return on Equity is forecast to be low in 3 years time (9.6%).